| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/13/2010 | CN100579523C Dihydroartemisinin emulsion for injection, freeze-dried emulsion and preparation method thereof |
| 01/13/2010 | CN100579522C Pasting agent |
| 01/13/2010 | CN100579519C Use of patchouli alcohol in preparing medicament for preventing and controlling senile dementia |
| 01/13/2010 | CN100579517C 'Longxuejie' soft capsule and preparation method thereof |
| 01/13/2010 | CN100579516C Vaginal effervescence tablet composition containing solid lipid |
| 01/13/2010 | CN100579515C Chewing tablet of malt and preparation method thereof |
| 01/13/2010 | CN100579514C Method for preparing particles through controlled agglomeration and method for increasing bioavailability |
| 01/13/2010 | CN100579513C Preparation method of lung targeting emodin polylactic acid microsphere |
| 01/13/2010 | CN100579512C Method of producing water-solubility hypocrellin titanium dioxide nano granule |
| 01/13/2010 | CN100579511C Ratification of highly purified tranexamic acid injection and quality standard thereof |
| 01/13/2010 | CN100579510C Precursor micelle preparation and its production process |
| 01/13/2010 | CN100579508C Oral-cleaning orally disintegrating tablet and preparing technique thereof |
| 01/13/2010 | CN100579399C Method for obtaining double products by processing sea cucumber and its preparation |
| 01/12/2010 | US7647620 Subtitling transmission system |
| 01/12/2010 | US7645816 Water-soluble compositions of bioactive lipophilic compounds |
| 01/12/2010 | US7645813 Mixture of addition copolymer and softener; transdermal |
| 01/12/2010 | US7645805 a core which is functionalized with three amino acid derived groups by means of an amide or urea linkage. It may be used to gelate or thicken numerous solvents |
| 01/12/2010 | US7645803 containing a saccharide for use in the treatment of dermal disorders including H2O; a saccharide; a nonionic surfactant such as polyoxyethylene glycol sorbitan monostearate, a polymeric agent selected from a bio-adhesive agent, gelling agent; film forming agent; phase change agent; adjuvant; propellant |
| 01/12/2010 | US7645793 Effective ingredient and basic agent; foam suppression |
| 01/12/2010 | US7645766 Method for treatment of depression and depressive mood disorders |
| 01/12/2010 | US7645736 injecting an alpha-v. beta 3 or alpha-v, beta 5 inhibitor into the vitreous body of the eye; angiogenesis inhibition; diabetic retinopathy, macular degeneration, myopia, ocular histoplasmosis; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 01/12/2010 | US7645511 Modified tire tread including particles of core-shell polymers of a crosslinked butadiene-styrene copolymer and an enriched shell of styrene polymer; low rolling resistance and reduced dynamic heat build-up; glass transition temperature imparts better wet traction |
| 01/12/2010 | US7645468 Oil seed meal preparation |
| 01/12/2010 | US7645462 Acupoint patch |
| 01/12/2010 | US7645460 Dosage forms of risedronate |
| 01/12/2010 | US7645459 Oral dosage form having pharmaceutically effective absorption comprising 1-500 mg of a bisphosphonate which is selected from risedronate and acids, salts, and esters thereof, 10-500 mg of EDTA, and a delayed release mechanism to deliver the bisphosphonate and the EDTA in the lower gastrointestinal tract |
| 01/12/2010 | US7645442 Device including heat source is operable to supply heat to substrate to produce substrate temperature greater than 300 degrees C., and to substantially volatilize drug composition film from substrate in 2 seconds or less |
| 01/12/2010 | US7645263 Impedance sensor |
| 01/12/2010 | US7644880 Particle-size reduction apparatus, and use thereof |
| 01/12/2010 | CA2545878C Compositions and methods for treating a posterior segment of an eye |
| 01/12/2010 | CA2528064C Low dose pharmaceutical powders for inhalation |
| 01/12/2010 | CA2466338C New uses for anti-malarial therapeutic agents |
| 01/12/2010 | CA2442906C Reconstitutable parenteral composition containing a cox-2 inhibitor |
| 01/12/2010 | CA2427467C Sn-38 lipid complexes and methods of use |
| 01/12/2010 | CA2407298C Mixtures of triblock polyesterpolyethylene glycol copolymers |
| 01/12/2010 | CA2373936C Nasogastric enteral formulations |
| 01/12/2010 | CA2369284C Three-dimensional structures containing hyaluronic acid derivatives obtained by the supercritical antisolvent technique |
| 01/07/2010 | WO2010003078A2 Melt granulation process |
| 01/07/2010 | WO2010003009A2 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors |
| 01/07/2010 | WO2010002965A2 Pneumonia treatment |
| 01/07/2010 | WO2010002763A1 Solid dosage formulations of telcagepant potassium |
| 01/07/2010 | WO2010002712A2 Method of crystallization |
| 01/07/2010 | WO2010002613A2 Method of making a dry powder pharmaceutical composition |
| 01/07/2010 | WO2010002563A1 Methods and ophtalmic devices used in the treatment of ocular allergies |
| 01/07/2010 | WO2010002473A1 Unit dosage of apadenoson |
| 01/07/2010 | WO2010002450A2 Micelles for delivery of nitric oxide |
| 01/07/2010 | WO2010002033A2 Tablet |
| 01/07/2010 | WO2010001932A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | WO2010001930A1 Solid preparation for internal application |
| 01/07/2010 | WO2010001926A1 Water-containing composition |
| 01/07/2010 | WO2010001671A1 Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle devive |
| 01/07/2010 | WO2010001574A1 Process for production of spherical microparticles comprising tamsulosin hydrochloride |
| 01/07/2010 | WO2010001413A2 Sustained release pharmaceutical compositions comprising quetiapine |
| 01/07/2010 | WO2010001325A2 Methods, compositions and systems for local delivery of drugs |
| 01/07/2010 | WO2010001267A2 Delivery product for topical compositions |
| 01/07/2010 | WO2010001063A1 Orodispersible mannitol |
| 01/07/2010 | WO2010000943A1 An intrauterine delivery system for contraception |
| 01/07/2010 | WO2010000904A1 Pharmaceutical composition with glycosaminoglycans and use thereof in the treatment of chronic ulcers |
| 01/07/2010 | WO2010000783A1 Method for coating tablets |
| 01/07/2010 | WO2010000740A1 Pharmaceutical dosage form comprising polymeric carrier composition |
| 01/07/2010 | WO2010000207A1 A natural allicin tablet and preparation method thereof |
| 01/07/2010 | WO2010000061A1 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness |
| 01/07/2010 | WO2009140557A3 Modified release tolterodine formulations |
| 01/07/2010 | WO2009140251A3 Medicament delivery device having an electronic circuit system |
| 01/07/2010 | WO2009138473A3 Intracellular antibody delivery |
| 01/07/2010 | WO2009129494A3 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation |
| 01/07/2010 | WO2009129464A3 Method for treating acute pain with a formulated drug depot in combination with a liquid formulation |
| 01/07/2010 | WO2009129336A3 Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections |
| 01/07/2010 | WO2009129155A3 Dexamethasone formulations in a biodegradable material |
| 01/07/2010 | WO2009126805A3 Therapeutic tarageting of mmps in neutral liposomes |
| 01/07/2010 | WO2009126738A3 Dried formulations |
| 01/07/2010 | WO2009122431A3 Oral controlled release tablet with reduced burst effect |
| 01/07/2010 | WO2009116078A3 Oral dosage form containing a pyridinol derivative |
| 01/07/2010 | WO2009116076A3 Ophthalmic preparation containing a pyridinol derivative |
| 01/07/2010 | WO2009115175A3 Lyophilized nanoemulsion |
| 01/07/2010 | WO2009114773A3 Modified release formulations of anti-irritability drugs |
| 01/07/2010 | WO2009079640A3 User interface improvements for medical devices |
| 01/07/2010 | WO2009010770A3 Dry-powder medicament |
| 01/07/2010 | WO2008151249A3 Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine |
| 01/07/2010 | WO2008141059A3 Lung volume reduction therapy using crosslinked non-natural polymers |
| 01/07/2010 | WO2008138755A3 Pharmaceutical compositions for poorly soluble drugs |
| 01/07/2010 | WO2007045116A8 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 01/07/2010 | US20100004753 Open-pore biocompatible surface layer for an implant, methods of production and use |
| 01/07/2010 | US20100004639 Drug-delivery pumps and methods of manufacture |
| 01/07/2010 | US20100004638 Implantable Infusion Devices With Overfill Protection |
| 01/07/2010 | US20100004637 System and method for implantation of devices having unknown biocompatible materials |
| 01/07/2010 | US20100004628 System for delivering a composition to the nasal membrane and method of using same |
| 01/07/2010 | US20100004311 Excitatory amino acid inhibitors for treating sensitive skins |
| 01/07/2010 | US20100004291 Liquid dosage forms of non-enterically coated acid-labile drugs |
| 01/07/2010 | US20100004172 Compositions for mucosal and oral administration comprising hcg fragments |
| 01/07/2010 | US20100004132 Modified inorganinc materials |
| 01/07/2010 | US20100003384 Effervescent powder formulation for beverages and its use |
| 01/07/2010 | US20100003338 Micelles for delivery of nitric oxide |
| 01/07/2010 | US20100003337 Functionalized poly(ether-anhydride) block copolymers |
| 01/07/2010 | US20100003336 Vesicles of self-assembling block copolymers and methods for making and using the same |
| 01/07/2010 | US20100003335 Microparticles for delivery to cells and/or tissue |
| 01/07/2010 | US20100003334 Combination of loteprednol etabonate and tobramycin for topical ophthalmic use |
| 01/07/2010 | US20100003333 Compositions and methods for treating digestive disorders |
| 01/07/2010 | US20100003332 Process For Preparing Powder Comprising Nanoparticles of Sparingly Soluble Drug |
| 01/07/2010 | US20100003331 Sustained release dosage forms of ziprasidone |